These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2985433)

  • 21. Possible role of distinct morphine and enkephalin receptors in mediating actins of benzomorphan drugs (putative kappa and sigma agonists).
    Chang KJ; Hazum E; Cuatrecasas P
    Proc Natl Acad Sci U S A; 1980 Aug; 77(8):4469-73. PubMed ID: 6254028
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological and anatomical evidence of selective mu, delta, and kappa opioid receptor binding in rat brain.
    Mansour A; Lewis ME; Khachaturian H; Akil H; Watson SJ
    Brain Res; 1986 Dec; 399(1):69-79. PubMed ID: 3026574
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differences of binding characteristics of non-selective opiates towards mu and delta receptor types.
    Delay-Goyet P; Roques BP; Zajac JM
    Life Sci; 1987 Aug; 41(6):723-31. PubMed ID: 3039270
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of opioid binding sites in rat spinal cord.
    Petrillo P; Kowalski J; Sbacchi M; Tavani A
    J Recept Res; 1992; 12(1):39-57. PubMed ID: 1314311
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective proliferation of brain kappa opiate receptors in spontaneously hypertensive rats.
    Bhargava HN; Das S
    Life Sci; 1986 Dec; 39(26):2593-600. PubMed ID: 3025539
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction of opiates with opioid binding sites in the bovine adrenal medulla: II. Interaction with kappa sites.
    Castanas E; Bourhim N; Giraud P; Boudouresque F; Cantau P; Oliver C
    J Neurochem; 1985 Sep; 45(3):688-99. PubMed ID: 2993510
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reversible and irreversible binding of beta-funaltrexamine to mu, delta and kappa opioid receptors in guinea pig brain membranes.
    Tam SW; Liu-Chen LY
    J Pharmacol Exp Ther; 1986 Nov; 239(2):351-7. PubMed ID: 3021954
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence for a kappa-opioid receptor on pituitary astrocytes: an autoradiographic study.
    Bunn SJ; Hanley MR; Wilkin GP
    Neurosci Lett; 1985 Apr; 55(3):317-23. PubMed ID: 2989733
    [TBL] [Abstract][Full Text] [Related]  

  • 29. (+)-[3H]SKF 10,047, (+)-[3H]ethylketocyclazocine, mu, kappa, delta and phencyclidine binding sites in guinea pig brain membranes.
    Tam SW
    Eur J Pharmacol; 1985 Feb; 109(1):33-41. PubMed ID: 2986989
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Affinities of some common opioid analgesics towards four binding sites in mouse brain.
    Neil A
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Nov; 328(1):24-9. PubMed ID: 6151117
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Solubilization and preliminary characterization of mu and kappa opiate receptor subtypes from rat brain.
    Chow T; Zukin RS
    Mol Pharmacol; 1983 Sep; 24(2):203-12. PubMed ID: 6310362
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of the kappa-subtype of the opiate receptor in the guinea-pig brain.
    Kosterlitz HW; Paterson SJ; Robson LE
    Br J Pharmacol; 1981 Aug; 73(4):939-49. PubMed ID: 6268235
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kappa-opiate binding to rat brain and guinea pig cerebellum: sensitivity towards ions and nucleotides.
    Itzhak Y; Pasternak GW
    Neurosci Lett; 1986 Feb; 64(1):81-4. PubMed ID: 3008039
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Binding characteristics of [3H]opioid ligands to active opioid binding sites solubilized from rat brain membranes by glycodeoxycholate and NaCl: the recovery of binding activity by dilution.
    Maruyama M; Sugino H; Akita K; Hatanaka H
    Brain Res; 1987 Jan; 401(1):14-22. PubMed ID: 2880641
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of methimazole-induced hypothyroidism on multiple opioid receptors in rat brain regions.
    Bhargava HN; Ramarao P; Gulati A
    Pharmacology; 1988; 37(6):356-64. PubMed ID: 2854273
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional opioid receptor sites in human placentas.
    Belisle S; Petit A; Gallo-Payet N; Bellabarba D; Lehoux JG; Lemaire S
    J Clin Endocrinol Metab; 1988 Feb; 66(2):283-9. PubMed ID: 2892853
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hydrodynamic parameters of opioid receptors from frog brain.
    Simon J; Benyhe S; Borsodi A; Wollemann M
    Neuropeptides; 1986 Jan; 7(1):23-6. PubMed ID: 3005907
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in multiple opioid receptors in regions of the brain in rats treated chronically with thyroxine.
    Bhargava HN; Ramarao P; Gulati A
    Neuropharmacology; 1989 Sep; 28(9):955-60. PubMed ID: 2554187
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Traumatic injury alters opiate receptor binding in rat spinal cord.
    Krumins SA; Faden AI
    Ann Neurol; 1986 May; 19(5):498-501. PubMed ID: 3013077
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autoradiographic localization of kappa opiate receptors to deep layers of the cerebral cortex may explain unique sedative and analgesic effects.
    Goodman RR; Snyder SH
    Life Sci; 1982 Sep 20-27; 31(12-13):1291-4. PubMed ID: 6128654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.